Search results for "FDA update"


 
Results 61 - 70 of about 231 for "FDA update".
Sort by: Relevance | Newest | Oldest

Major Tylenol recall; FDA concerned about BPA and children

Approvals, recalls, and other regulatory news.
https://immattersacp.org/archives/2010/03/fda.htm
1 Mar 2010

FDA bans dozens of generics from entering U.S. for quality

The latest recalls, warnings, label changes and approvals from the Food and Drug Administration.
https://immattersacp.org/archives/2008/11/fda.htm
1 Nov 2008

Shingles vaccine age range extended; aneurysm kit approved

Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/06/fda.htm
1 Jun 2011

Leflunomide gets boxed warning, ARBs under review

Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2010/09/fda.htm
1 Sep 2010

New meningitis vaccine, hepatitis C drug approved

Recalls and approvals.
https://immattersacp.org/archives/2015/01/fda.htm
1 Jan 2015

Warnings issued for antiepileptics, bowel prep, efalizumab

A summary of approvals, recalls, warnings and alerts.
https://immattersacp.org/archives/2009/02/fda.htm
1 Feb 2009

Recalls for arrhythmia drug, infusion pumps, defibrillators

A summary of approvals, recalls, warnings and alerts from the Food and Drug Administration.
https://immattersacp.org/archives/2009/05/fda.htm
1 May 2009

Warnings on power cords, asthma drugs, diabetes supplies

A summary of approvals, recalls, warnings and alerts digested by ACP Internist from the Food and Drug Administration's alerts.
https://immattersacp.org/archives/2009/11/fda.htm
1 Nov 2009

Digoxin, Biosite Triage Cardiac Panel, insulin pumps recalled

A summary of approvals, recalls, warnings and alerts digested by ACP Internist from the Food and Drug Administration's alerts.
https://immattersacp.org/archives/2009/07/fda.htm
1 Jul 2009

FDA UPDATE Recalls, warnings andlabel changes A recall by ...

FDA UPDATE. Recalls, warnings andlabel changes. A recall by Med PrepConsulting of all lots of allproducts compounded at itsfacility due to a report of visible mold infive bags of magnesium sulfate ... The FDA is requiring fivepostmarketing studies: a car-diovascular outcomes trial; anenhanced pharmacovigilanceprogram to monitor for malig-nancies, serious cases of pan-creatitis, severe hypersensitiv-ity reactions, photosensitivityreactions, liver abnormalities,and
https://immattersacp.org/archives/2013/06/acpi-201306-coding_t1.pdf
23 May 2013

Result Page: Prev   2   3   4   5   6   7   8   9   10   11   Next